Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2018-07
  • Trilaurin (Glycerol Tridodecanoate): Lab Protocols & QC Guid

    2026-06-05

    Trilaurin (Glycerol Tridodecanoate): Practical Laboratory Protocols and Quality Control

    What This Product Solves

    Trilaurin (Glycerol Tridodecanoate, CAS No. 538-24-9) is a synthetic long-chain triacylglycerol (C12) designed to address reproducibility challenges in lipid-based research and formulation. Its standardized composition and defined solubility profile enable its use as a lipid excipient for solid lipid microparticles, as a substrate in biocatalytic synthesis, and as a carrier in oral delivery of peptide and protein drugs. Trilaurin’s physicochemical stability and compatibility with organic solvents make it especially suitable for protocols where precise lipid quantification and robust batch-to-batch performance are critical. However, its insolubility in water and sensitivity to prolonged storage restrict its use in certain aqueous or long-term applications.

    Protocol Parameters

    • Solubility in DMSO: ≥2.37 mg/mL (with gentle warming and ultrasonic treatment) | Prepares concentrated stock solutions for biocatalytic assays and nanoparticle formulation | Ensures full dissolution for downstream reactions and uniformity in lipid dispersions | product information
    • Solubility in Ethanol: ≥24.45 mg/mL | Facilitates high-concentration stock preparation for protocols requiring organic solvent delivery | Supports workflows with high lipid loading or solvent-based film hydration steps | product information
    • Enzymatic Substrate Concentration: 2 mM (e.g., for lipase-catalyzed fatty amine synthesis at 30°C for 20 hours) | Biocatalytic synthesis of laurylamine and related products | Balances substrate conversion efficiency and enzyme stability without phase separation | product information
    • Storage Temperature: -20°C (solid form) | Maintains compound integrity over time | Prevents hydrolysis and oxidative degradation of fatty acid side chains | product information
    • Recommended Solution Use: Short-term only | Critical for maintaining consistency in lipid nanoparticle and SLM protocols | Limits risk of hydrolysis or aggregation during storage | product information

    Workflow Setup and QC Checklist

    To ensure consistent performance of Trilaurin (SKU BA7536) in research workflows, implement the following setup and quality control (QC) practices:

    • Pre-dispersion Treatment: For DMSO preparations, apply gentle warming (up to 40°C) and brief ultrasonic agitation to achieve complete dissolution. For ethanol, verify full solubilization visually before use.
    • Solution Preparation Timing: Prepare all Trilaurin solutions immediately prior to use, as both DMSO and ethanol stocks are prone to precipitation or degradation upon extended storage.
    • Particle Size and Homogeneity: When formulating solid lipid microparticles or lipid nanoparticles, use dynamic light scattering or microscopy to confirm uniform particle size distribution post-assembly.
    • Substrate Loading Verification: For biocatalytic synthesis, confirm Trilaurin input concentrations by gravimetric or HPLC methods before enzyme addition to ensure accurate stoichiometry.
    • Storage and Handling: Maintain the solid at -20°C; minimize freeze-thaw cycles. Record all storage and handling events for traceability.
    • Batch Consistency: For critical pharmaceutical or biochemical applications, document lot numbers and retain reference aliquots for retrospective QC.

    The internal article "Trilaurin (Glycerol Tridodecanoate): Reliable Workflows in Lipid-Based Assays" provides scenario-based recommendations for troubleshooting and optimizing lipid-based protocols using Trilaurin. For detailed procedures in biocatalytic synthesis and nanoparticle preparation, see "Trilaurin (Glycerol Tridodecanoate): Applied Biocatalysis & Delivery".

    Common Failure Modes and Fixes

    • Incomplete Dissolution: If visible particulates persist after recommended warming and sonication, confirm solvent purity and increase agitation duration. Avoid excessive heating (>40°C) to prevent degradation.
    • Precipitation During Storage: If precipitation occurs in DMSO or ethanol stocks, re-dissolve with gentle warming before use. Discard solutions showing discoloration or phase separation.
    • Variable Particle Size in Nanoparticle Formation: Adjust homogenization parameters or surfactant concentration if dynamic light scattering reveals broad or bimodal distributions.
    • Substrate Inhibition in Enzymatic Reactions: If conversion yields drop at higher substrate concentrations, optimize enzyme-to-substrate ratios and confirm absence of residual solvents or impurities.
    • Unexpected Hydrolysis: Ensure all glassware and solvents are dry, and minimize exposure to ambient humidity during weighing and transfer steps.

    Scope and Limitations

    Trilaurin is best suited for workflows requiring a standardized triacylglycerol C12 substrate in organic solvent-based systems, including as a lipid excipient for solid lipid microparticles and as a biocatalytic synthesis substrate. Its insolubility in water limits its use in aqueous phase formulations or direct in vivo aqueous dosing. Long-term storage of solutions is not recommended due to risk of hydrolysis and precipitation; only the solid form is stable at -20°C. Trilaurin is not suitable for applications requiring rapid dissolution in neutral or buffered aqueous media. For workflows requiring sustained release or long-term stability in water, alternative excipients should be considered.

    Conclusion

    Trilaurin (Glycerol Tridodecanoate, SKU BA7536) offers a robust, reproducible foundation for lipid nanoparticle assembly, enzymatic biocatalysis, and advanced oral drug delivery research when used within its solubility and stability parameters. Proper protocol execution and QC monitoring are essential to realize its benefits. Researchers can find detailed product specifications and ordering information at Trilaurin via APExBIO. Always align handling and assay design with dossier constraints to maximize reliability and reproducibility in your laboratory workflows.